SeromYx supports the biopharma industry in vaccine and immunotherapeutic product development, and targets range from blockbuster indications to neglected tropical diseases (NTD), with significant contributions to the fight against SARS-COV-2.  Driven by client demand, we expect to double in size as we support discovery and development of second-generation coronavirus vaccines, including BLA-enabling studies. Additionally, our business is also expanding in the NTD and in new therapeutic areas such as autoimmunity and oncology.  As a further consequence of our success, we have outgrown our space in Cambridge and will be moving into new build custom labs in Woburn, MA.  in Q2 2022.

Stay tuned for new positions.

Applicants should send their cover letter and resume to jobs@seromyx.com.